Categories Earnings, Health Care

Allergan beats estimates on Q1 results, raises full-year guidance

Allergan plc (NYSE: AGN) topped market forecasts on revenue and earnings for the first quarter of 2019. Despite the beat, shares fell 0.5% in premarket hours on Tuesday.

Total revenue decreased 2% year-over-year to $3.60 billion. The company’s core business grew 4.4% year-over-year across its four key therapeutic areas, helped by growth of products such as BOTOX Cosmetic, BOTOX Therapeutic, VRAYLAR, JUVEDERM and Lo LOESTRIN.

Allergan reports first quarter 2019 earnings

GAAP net loss attributable to ordinary shareholders was $2.4 billion, or $7.25 per share, versus $332.5 million, or $0.99 per share, in the year-ago period. Adjusted EPS grew 1.3% to $3.79.

In US Specialized Therapeutics, revenues decreased 2.3% year-over-year to $1.54 billion due to lower revenues in CoolSculpting and RESTASIS as well as the divestiture of the Medical Dermatology business, which offset the demand growth in BOTOX and JUVEDERM.

US General Medicine revenues grew 2.1% to $1.25 billion, primarily due to growth in VRAYLAR and Lo LOESTRIN. International revenues grew 1.3% to $801.5 million, due to growth in Facial Aesthetics.

Also see: Allergan Q1 2019 Earnings Conference Call Transcript

Allergan raised its outlook for the full year of 2019, and now expects GAAP net revenues to be in the range of $15.12 billion to $15.42 billion. Adjusted revenues are expected to be $15.10 billion to $15.40 billion. GAAP loss is expected to be $5.70 per share while adjusted EPS is expected to be $16.55.

For the second quarter of 2019, GAAP revenues are expected to be $3.87 billion to $4.02 billion. Adjusted revenues are expected to be $3.85 billion to $4.00 billion. GAAP EPS is expected to come in the range of $0.50-0.70 while adjusted EPS is expected to be $4.20-4.40.

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

Earnings Preview: FedEx looks set to report mixed results for Q4 2025

FedEx Corp. (NYSE: FDX) is preparing to report fourth-quarter earnings on Tuesday, June 24, at 4:00 pm ET. Recently, the management lowered its full-year earnings and revenue guidance for the

How Ulta Beauty’s (ULTA) new strategy is fueling growth

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) were up over 1% on Monday. The stock has gained 31% over the past three months. The beauty retailer started fiscal year 2025

Earnings Preview: What to look for when Kroger (KR) reports Q1 2025 results

The Kroger Co. (NYSE: KR) is expected to report its first-quarter financial results next week. Customer engagement remained stable last year, driven by high-quality products and tailored promotional offers. Recently,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top